Article info
PDFAsthma
The role of a soluble TNFα receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial
- Dr J B Morjaria, Mailpoint 810, South Academic Block, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK; jbm{at}soton.ac.uk
Citation
The role of a soluble TNFα receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial
Publication history
- Received June 28, 2007
- Accepted December 19, 2007
- First published February 1, 2008.
Online issue publication
September 01, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
web only appendix 63/7/584
Files in this Data Supplement:
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group Ltd and the British Thoracic Society